These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

841 related articles for article (PubMed ID: 27298100)

  • 1. Progress in surgical and nonsurgical approaches for hepatocellular carcinoma treatment.
    Yegin EG; Oymaci E; Karatay E; Coker A
    Hepatobiliary Pancreat Dis Int; 2016 Jun; 15(3):234-56. PubMed ID: 27298100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in non-surgical management of primary liver cancer.
    Chen X; Liu HP; Li M; Qiao L
    World J Gastroenterol; 2014 Nov; 20(44):16630-8. PubMed ID: 25469032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma.
    Llovet JM; De Baere T; Kulik L; Haber PK; Greten TF; Meyer T; Lencioni R
    Nat Rev Gastroenterol Hepatol; 2021 May; 18(5):293-313. PubMed ID: 33510460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Updates and advancements in the management of hepatocellular carcinoma patients after hepatectomy.
    Lu SD; Li L; Liang XM; Chen W; Chen FL; Fan LL; Ahir BK; Zhang WG; Zhong JH
    Expert Rev Gastroenterol Hepatol; 2019 Nov; 13(11):1077-1088. PubMed ID: 31648568
    [No Abstract]   [Full Text] [Related]  

  • 5. Adjuvant therapy for hepatocellular carcinoma: current situation and prospect.
    Wang Z; Zhang G; Wu J; Jia M
    Drug Discov Ther; 2013 Aug; 7(4):137-43. PubMed ID: 24071575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Goals and targets for personalized therapy for HCC.
    Couri T; Pillai A
    Hepatol Int; 2019 Mar; 13(2):125-137. PubMed ID: 30600478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment algorithm for intermediate and advanced stage hepatocellular carcinoma: Korea.
    Choi JY
    Oncology; 2011; 81 Suppl 1():141-7. PubMed ID: 22212948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical Management of Hepatocellular Carcinoma.
    Rich NE; Yopp AC; Singal AG
    J Oncol Pract; 2017 Jun; 13(6):356-364. PubMed ID: 28605614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective.
    Poon RT; Fan ST; Tsang FH; Wong J
    Ann Surg; 2002 Apr; 235(4):466-86. PubMed ID: 11923602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of locoregional therapy before living donor liver transplantation in patients with hepatocellular carcinoma who meet the Milan criteria.
    Kim JM; Kwon CH; Joh JW; Choi MS; Lee JH; Koh KC; Paik SW; Kim GS; Kim SJ; Lee SK; Yoo BC
    Transplant Proc; 2012 Mar; 44(2):403-8. PubMed ID: 22410028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current management of hepatocellular carcinoma.
    Tabrizian P; Roayaie S; Schwartz ME
    World J Gastroenterol; 2014 Aug; 20(30):10223-37. PubMed ID: 25132740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanded use of aggressive therapies improves survival in early and intermediate hepatocellular carcinoma.
    Ho EY; Cozen ML; Shen H; Lerrigo R; Trimble E; Ryan JC; Corvera CU; Monto A;
    HPB (Oxford); 2014 Aug; 16(8):758-67. PubMed ID: 24467780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of Recurrent HCC After Liver Transplantation.
    Sarici B; Isik B; Yilmaz S
    J Gastrointest Cancer; 2020 Dec; 51(4):1197-1199. PubMed ID: 32839944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical roundtable monograph. Integrating recent data in managing adverse events in the treatment of hepatocellular carcinoma.
    Gish RG; Abou-Alfa GK; Tong MJ
    Clin Adv Hematol Oncol; 2010 Sep; 8(9):2 p preceding 4-15. PubMed ID: 21598749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in the surgical treatment of hepatocellular carcinoma.
    Morise Z; Kawabe N; Tomishige H; Nagata H; Kawase J; Arakawa S; Yoshida R; Isetani M
    World J Gastroenterol; 2014 Oct; 20(39):14381-92. PubMed ID: 25339825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in Local and Systemic Therapies for Hepatocellular Cancer.
    Mokdad AA; Singal AG; Yopp AC
    Curr Oncol Rep; 2016 Feb; 18(2):9. PubMed ID: 26769114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular carcinoma downstaging in liver transplantation.
    Yu CY; Ou HY; Huang TL; Chen TY; Tsang LL; Chen CL; Cheng YF
    Transplant Proc; 2012 Mar; 44(2):412-4. PubMed ID: 22410030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Updated treatment approach to hepatocellular carcinoma.
    Llovet JM
    J Gastroenterol; 2005 Mar; 40(3):225-35. PubMed ID: 15830281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-disciplinary Concurrent Management of Recurrent Hepatocellular Therapy is Superior to Sequential Therapy.
    Fields TD; Philips P; Scoggins CR; Tatum C; Kelly L; McMasters KM; Martin RCG
    World J Surg; 2017 May; 41(5):1331-1339. PubMed ID: 27905019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of hepatocellular in the United States.
    Mokdad AA; Hester CA; Singal AG; Yopp AC
    Chin Clin Oncol; 2017 Apr; 6(2):21. PubMed ID: 28482674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.